Sort
82,697 grants matching “vaccine development”
Biologically informed design of CD8+ T cell-dependent pre-erythrocytic stage malaria vaccines
$1,242,198Stefan H.i. Kappe · Seattle Children'S Hospital · U01 · FY2024 · AI
Biologically informed design of CD8+ T cell-dependent pre-erythrocytic stage malaria vaccines
$1,242,198Stefan H.i. Kappe · Seattle Children'S Hospital · U01 · FY2023 · AI
Clinical Evaluation of Novel Adenovirus Prime-Boost HIV-1 Vaccine
$1,241,912Raphael Dolin · Beth Israel Deaconess Medical Center · U19 · FY2011 · AI
Herpesvirus Pathogenesis and Vaccine Development
$1,241,754Jeffrey Cohen · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Allergen and T-Cell Reagent Resources for the Study of Allergic Diseases
$1,241,739Alessandro Sette · La Jolla Institute For Immunology · N01 · FY2010 · AI
Systems Biology Approaches to Molecular Diagnostics and Antiviral Drug Targeting
$1,241,687W. Ian Lipkin · Columbia University Health Sciences · U19 · FY2017 · AI
Administrative
$1,241,265Douglas D Richman · University Of California, San Diego · P30 · FY2016 · AI
Developing and Testing a Multi-level Package of Interventions for an Integrated Care Delivery Model of HIV Prevention and Treatment Targeting Adolescent Girls in Zambia
$1,241,046Sujha Subramanian · Research Triangle Institute · UG3 · FY2019 · HD
Comprehensive Minority and Health Disparities Research Center - Phase III
$1,240,829Mona N. Fouad · University Of Alabama At Birmingham · P60 · FY2012 · MD
Enhancing immunity to malaria in young children with effective chemoprevention
$1,240,701Prasanna Jagannathan · Stanford University · U01 · FY2022 · AI
Mechanisms Of Immune Mediated Restriction Of HIV Replication In LTNP
$1,240,321Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Development Of Flow Cytometric Technologies For Immune Assays
$1,240,161Mario Roederer · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Immunologic Correlates of Immunization for Cancer
$1,240,135University Of Washington · U54 · FY2003 · CA
Enhancing immunity to malaria in young children with effective chemoprevention
$1,240,005Prasanna Jagannathan · Stanford University · U01 · FY2024 · AI
Advanced Development of Vaccines for Filoviruses
$1,239,978John Eldridge · Auro Vaccines Llc · N01 · FY2022 · AI
Direct and Indirect Protection by Influenza Vaccine Given to Children in India
$1,239,966Wayne M Sullender · University Of Alabama At Birmingham · U01 · FY2008 · IP
A Phase II Evaluation of the Safety and Protective Efficacy of the Live Attenuated Tetravalent Dengue Vaccine TetraVax-DV with Challenge by the Recombinant DENV-2 Virus in a Dengue Endemic Population
$1,239,797Beth Diane Kirkpatrick · University Of Vermont & St Agric College · U01 · FY2022 · AI
The effect of peptide therapy and allergen provocation on Fel d1-specific T Cells
$1,239,733Mark Larche · Mcmaster University · U19 · FY2015 · AI
Genomic profiling of influenza infections to identify biomarkers of disease severity
$1,239,603Elodie Ghedin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Comparative Study of Influenza Vaccines in Adults
$1,239,569University Of Michigan At Ann Arbor · U01 · FY2004 · AI
Mechanisms of Early-life Immunity Associated with HIV-1 Vaccine-induced Neutralizing Antibody Responses
$1,239,565Wilton B Williams · Duke University · U01 · FY2025 · AI
Novel focused ultrasound enhanced calreticulin-nanoparticle for immune primed melanoma immunotherapy
$1,239,509Ashish Ranjan · Ut Southwestern Medical Center · R37 · FY2025 · CA
Optimization of Antibiotics in Mothers and their Breastfed Infants Using Pharmacomicrobiomic and Metabolomic Analyses
$1,239,102Adriana H Tremoulet · University Of California, San Diego · P50 · FY2023 · HD
Optimization of a new adaptive intervention to increase COVID-19 testing among people at high risk in an urban community
$1,239,077Liliane Cambraia Windsor · University Of Illinois At Urbana-Champaign · R01 · FY2021 · MD
Env evolution in humans and RMs
$1,238,707George M Shaw · University Of Pennsylvania · P01 · FY2018 · AI